Document Library

Document filter
Document Order


Training Presentation

Presentation on small short journey transport containers

11th September, 2017 : Adobe PDF Document (2061K)

Download Document

3cellscreen3517profile.pdf

8th September, 2017 : Adobe PDF Document (37K)

Download Document

Certificate 3 Cellscreen 3517.pdf

Certificate of conformance 3 cellscreen 3517

8th September, 2017 : Adobe PDF Document (132K)

Download Document

Certificate IgG 3292.pdf

8th September, 2017 : Adobe PDF Document (132K)

Download Document

Certificate ABO Controls 3282.pdf

Certificate of Conformance ABO Controls 3282

7th September, 2017 : Adobe PDF Document (150K)

Download Document

Certificate ABO Controls 3282.pdf (1)

7th September, 2017 : Adobe PDF Document (150K)

Download Document

Certificate of conformance Weak Anti-c N042 3052.pdf

Certificate of conformance Weak Anti-c N042 3052

7th September, 2017 : Adobe PDF Document (133K)

Download Document

September 2017 RCI User Information leaflet

Red Cell Immunohaematology (RCI) NHSBT offers a range of reference testing services which provide vital support for blood transfusion, organ and stem cell transplantation by ensuring the safety and clinical efficacy of transfusion and transplantation.

5th September, 2017 : Adobe PDF Document (320K)

Download Document

INF168.2 Antenatal Screening Services Leaflet

Antenatal Screening Testing women for ABO, RhD and screening for irregular antibodies are key elements in the prevention and treatment of Haemolytic Disease of the Fetus and Newborn (HDFN). NHS Blood and Transplant (NHSBT) has great expertise and experience in blood grouping and the detection and identification of antibodies. The Red Cell Immunohaematology (RCI) department has the infrastructure, scientific and clinical knowledge to deliver an antenatal screening service across England.

5th September, 2017 : Adobe PDF Document (351K)

Download Document

SPN214/4 The clinical significance of blood group alloantibodies and the supply of blood for transfusion

This document outlines current knowledge on the clinical significance of blood group alloantibodies. Its prime purpose is to enable clinical decisions to be made regarding the management and blood transfusion support of patients with blood group antibodies that are not commonly encountered and for which antigen-negative blood is not available in the routine stock. The overall aim is to ensure that a uniform RCI Clinical Policy for the supply of blood for transfusion is implemented throughout the NHSBT.

4th September, 2017 : Adobe PDF Document (783K)

Download Document